Antidepressant drugs transactivate trkb neurotrophin receptors in the adult rodent brain independently of bdnf and monoamine transporter blockade

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Rantamäki, Tomi ^a   Vesa, Liisa ^a   Antila, Hanna ^a   Lieto, Antonio ^a   Tammela, Päivi ^a   Schmitt, Angelika ^b   Lesch, Klaus Peter ^b   Rios, Maribel ^c   Castrén, Eero ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CITALOPRAM; CLOMIPRAMINE; FLUOXETINE; IMIPRAMINE; NORADRENALIN; REBOXETINE; SEROTONIN; SEROTONIN TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; IN VITRO STUDY; IN VIVO STUDY; MONOAMINE NERVE CELL; MOUSE; NONHUMAN; PREFRONTAL CORTEX; PROTEIN GLYCOSYLATION; PROTEIN PHOSPHORYLATION; TRANSACTIVATION;

AGING; AMITRIPTYLINE; ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; GLYCOSYLATION; IMIPRAMINE; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; RECEPTOR, TRKB; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TRANSCRIPTIONAL ACTIVATION; VESICULAR MONOAMINE TRANSPORT PROTEINS;

MUS; MUS MUSCULUS; RODENTIA;

EID: 79958150004     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020567     Document Type: Article

References (49)

1. McAllister AK, Katz LC, Lo DC, (1999) Neurotrophins and synaptic plasticity. Annu Rev Neurosci 22: 295-318.
2. McAllister AK, Lo DC, Katz LC, (1995) Neurotrophins regulate dendritic growth in developing visual cortex. Neuron 15: 791-803.
3. Huang EJ, Reichardt LF, (2001) Neurotrophins: Roles in neuronal development and function. Annu Rev Neurosci 24: 677-736.
4. Poo MM, (2001) Neurotrophins as synaptic modulators. Nat Rev Neurosci 2: 24-32.
5. Thoenen H, (1995) Neurotrophins and neuronal plasticity. Science 270: 593-598.
6. Lee FS, Chao MV, (2001) Activation of trk neurotrophin receptors in the absence of neurotrophins. Proc Natl Acad Sci U S A 98: 3555-3560.
7. Rajagopal R, Chen ZY, Lee FS, Chao MV, (2004) Transactivation of trk neurotrophin receptors by G-protein-coupled receptor ligands occurs on intracellular membranes. J Neurosci 24: 6650-6658.
8. Huang YZ, McNamara JO, (2010) Mutual regulation of src family kinases and the neurotrophin receptor TrkB. J Biol Chem 285: 8207-8217.
9. Jang SW, Liu X, Chan CB, Weinshenker D, Hall RA, et al. (2009) Amitriptyline is a TrkA and TrkB receptor agonist that promotes TrkA/TrkB heterodimerization and has potent neurotrophic activity. Chem Biol 16: 644-656.
10. Pezet S, Malcangio M, (2004) Brain-derived neurotrophic factor as a drug target for CNS disorders. Expert Opin Ther Targets 8: 391-399.
11. Schindowski K, Belarbi K, Buee L, (2008) Neurotrophic factors in Alzheimer's disease: Role of axonal transport. Genes Brain Behav 7 (Suppl 1): 43-56.
12. Rantamäki T, Castrén E, (2008) Targeting TrkB neurotrophin receptor to treat depression. Expert Opin Ther Targets 12: 705-15.
13. Saarelainen T, Hendolin P, Lucas G, Koponen E, Sairanen M, et al. (2003) Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J Neurosci 2: 349-357.
14. Sairanen M, Lucas G, Ernfors P, Castrén M, Castrén E, (2005) Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J Neurosci 25: 1089-1094.
15. Rantamäki T, Hendolin P, Kankaanpää A, Mijatovic J, Piepponen P, et al. (2007) Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-cgamma signaling pathways in mouse brain. Neuropsychopharmacology 32: 2152-2162.
16. Nibuya M, Morinobu S, Duman RS, (1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15: 7539-7547.
17. Monteggia LM, Luikart B, Barrot M, Theobold D, Malkovska I, et al. (2007) Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol Psychiatry 61: 187-97.
18. Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT, (2001) Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 50: 260-265.
19. Sen S, Duman R, Sanacora G, (2008) Serum brain-derived neurotrophic factor, depression, and antidepressant medications: Meta-analyses and implications. Biol Psychiatry 64: 527-532.
20. Wyneken U, Sandoval M, Sandoval S, Jorquera F, Gonzalez I, et al. (2006) Clinically relevant doses of fluoxetine and reboxetine induce changes in the TrkB content of central excitatory synapses. Neuropsychopharmacology 31: 2415-23.
21. Chen X, Ye H, Kuruvilla R, Ramanan N, Scangos KW, et al. (2005) A chemical-genetic approach to studying neurotrophin signaling. Neuron 46: 13-21.
22. Koponen E, Voikar V, Riekki R, Saarelainen T, Rauramaa T, et al. (2004) Transgenic mice overexpressing the full-length neurotrophin receptor trkB exhibit increased activation of the trkB-PLCgamma pathway, reduced anxiety, and facilitated learning. Mol Cell Neurosci 26: 166-181.
23. Koponen E, Lakso M, Castrén E, (2004) Overexpression of the full-length neurotrophin receptor trkB regulates the expression of plasticity-related genes in mouse brain. Brain Res Mol Brain Res 130: 81-94.
24. Watson FL, Porcionatto MA, Bhattacharyya A, Stiles CD, Segal RA, (1999) TrkA glycosylation regulates receptor localization and activity. J Neurobiol 39: 323-336.
25. Lee FS, Rajagopal R, Chao MV, (2002) Distinctive features of trk neurotrophin receptor transactivation by G protein-coupled receptors. Cytokine Growth Factor Rev 13: 11-17.
26. Miranda C, Di Virgilio M, Selleri S, Zanotti G, Pagliardini S, et al. (2002) Novel pathogenic mechanisms of congenital insensitivity to pain with anhidrosis genetic disorder unveiled by functional analysis of neurotrophic tyrosine receptor kinase type 1/nerve growth factor receptor mutations. J Biol Chem 277: 6455-6462.
27. Lu B, Pang PT, Woo NH, (2005) The yin and yang of neurotrophin action. Nat Rev Neurosci 6: 603-614.
28. Rios M, Fan G, Fekete C, Kelly J, Bates B, et al. (2001) Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol 15: 1748-1757.
29. Wiese S, Jablonka S, Holtmann B, Orel N, Rajagopal R, et al. (2007) Adenosine receptor A2A-R contributes to motoneuron survival by transactivating the tyrosine kinase receptor TrkB. Proc Natl Acad Sci U S A 104: 17210-17215.
30. Sebastiao AM, Ribeiro JA, (2009) Triggering neurotrophic factor actions through adenosine A2A receptor activation: Implications for neuroprotection. Br J Pharmacol 158: 15-22.
31. Phillis JW, Wu PH, (1982) The effect of various centrally active drugs on adenosine uptake by the central nervous system. Comp Biochem Physiol C 72: 179-187.
32. Pires VA, Pamplona FA, Pandolfo P, Fernandes D, Prediger RD, et al. (2009) Adenosine receptor antagonists improve short-term object-recognition ability of spontaneously hypertensive rats: A rodent model of attention-deficit hyperactivity disorder. Behav Pharmacol 20: 134-145.
33. Lobato KR, Binfare RW, Budni J, Rosa AO, Santos AR, et al. (2008) Involvement of the adenosine A1 and A2A receptors in the antidepressant-like effect of zinc in the forced swimming test. Prog Neuropsychopharmacol Biol Psychiatry 32: 994-999.
34. Shen HW, Hagino Y, Kobayashi H, Shinohara-Tanaka K, Ikeda K, et al. (2004) Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. Neuropsychopharmacology 29: 1790-1799.
35. Duman RS, Monteggia LM, (2006) A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59: 1116-27.
36. Siuciak JA, Lewis DR, Wiegand SJ, Lindsay RM, (1997) Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav 56: 131-137.
37. Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS, (2002) Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 22: 3251-3261.
38. Koponen E, Rantamäki T, Voikar V, Saarelainen T, Macdonald E, et al. (2005) Enhanced BDNF signaling is associated with an antidepressant-like behavioral response and changes in brain monoamines. Cell Mol Neurobiol 25: 973-980.
39. Saarelainen T, Vaittinen S, Castrén E, (2001) TrkB-receptor activation contributes to the kainate-induced increase in BDNF mRNA synthesis. Cell Mol Neurobiol 21: 429-435.
40. Martinowich K, Lu B, (2008) Interaction between BDNF and serotonin: Role in mood disorders. Neuropsychopharmacology 33: 73-83.
41. Mattson MP, Maudsley S, Martin B, (2004) BDNF and 5-HT: A dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci 27: 589-594.
42. Lucchelli A, Santagostino-Barbone MG, Barbieri A, Candura SM, Tonini M, (1995) The interaction of antidepressant drugs with central and peripheral (enteric) 5-HT3 and 5-HT4 receptors. Br J Pharmacol 114: 1017-1025.
43. Raabe R, Gentile L, (2008) Antidepressant interactions with the NMDA NR1-1b subunit. J Biophys 2008: 474205.
44. Rammes G, Rupprecht R, (2007) Modulation of ligand-gated ion channels by antidepressants and antipsychotics. Mol Neurobiol 35: 160-174.
45. Narita N, Hashimoto K, Tomitaka S, Minabe Y, (1996) Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain. Eur J Pharmacol 307: 117-119.
46. Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, et al. (1998) Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("ecstasy") in serotonin transporter-deficient mice. Mol Pharmacol 53: 649-655.
47. Murphy DL, Lesch KP, (2008) Targeting the murine serotonin transporter: Insights into human neurobiology. Nat Rev Neurosci 9: 85-96.
48. Vesa J, Kruttgen A, Shooter EM, (2000) p75 reduces TrkB tyrosine autophosphorylation in response to brain-derived neurotrophic factor and neurotrophin 4/5. J Biol Chem 275: 24414-24420.
49. Rantamäki T, Knuuttila JE, Hokkanen ME, Castrén E, (2006) The effects of acute and long-term lithium treatments on trkB neurotrophin receptor activation in the mouse hippocampus and anterior cingulate cortex. Neuropharmacology 50: 421-427.